Developing personalised therapies for Uveal Melanoma: Understanding disease process and validation of therapeutic targets


Prof Breandán N Kennedy, is a professor of Biomolecular & Biomed Science in the Conway Institute.  The goal of his research team is to develop genetic and pharmacological treatments for human blindness.

Uveal melanoma (UV) is a cancer of the eye involving the iris, ciliary body, or choroid (collectively referred to as the uvea).  Ireland has a very high incidence of this cancer, with some experts speculating that it is one of the highest incidences worldwide.  

Start year:
Principal Investigator:
Prof Breandán N Kennedy
UCD Conway Institute, University College Dublin
Grant funding:
BCR project grant
Linked Breakthrough Research Priorities:
1,2,3, 4,5

View More